Text Size

Personality Type as a Predictor to Develop Depression and Reduction in Quality of Life Among Stroke Survivals. (TPQ BDI SSQOL)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
d_yarnitsky, Rambam Health Care Campus
ClinicalTrials.gov Identifier:
NCT00845455
First received: February 15, 2009
Last updated: October 24, 2011
Last verified: October 2011
History of Changes
  Purpose

Personality type as a predictor to develop depression and reduction in quality of life among stroke survivals.


Condition
Stroke
Depression
Quality of Life
Personality Type

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Personality Type as a Predictor to Develop Depression and Reduction in Quality of Life Among Stroke Survivals.

Resource links provided by NLM:

MedlinePlus related topics: Depression
U.S. FDA Resources

Further study details as provided by Rambam Health Care Campus:

Primary Outcome Measures:
  • Depression [ Time Frame: 1-3 month post stroke ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • QOL post stroke [ Time Frame: 1-3 month post stroke ] [ Designated as safety issue: No ]

Enrollment: 85
Study Start Date: November 2007
Study Completion Date: June 2009
Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)
Groups/Cohorts
1. Harm Avoidance
Personality type
2. Reward Dependence
Personality type
3. Novelty Seeking
Personality type

  Eligibility

Ages Eligible for Study:   40 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Stroke ( TIA, CVA, ICH ) patients

Criteria

Inclusion Criteria:

  • any stroke,
  • age 40-90,
  • able to sigh informed concent,
  • able to fill in the questionnaires.

Exclusion Criteria:

  • non stroke,
  • previous depression,
  • not able to give consent or answer the questions.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00845455

Sponsors and Collaborators
d_yarnitsky
Investigators
Principal Investigator: David - Yarnitsky, Prof.
  More Information

No publications provided

Responsible Party: d_yarnitsky, MD, Rambam Health Care Campus
ClinicalTrials.gov Identifier: NCT00845455     History of Changes
Other Study ID Numbers: TPQStroke03CTIL
Study First Received: February 15, 2009
Last Updated: October 24, 2011
Health Authority: Israel: Ministry of Health

Additional relevant MeSH terms:
Personality Disorders
Depression
Depressive Disorder
Stroke
Cerebral Infarction
Mental Disorders
Behavioral Symptoms
Mood Disorders
 Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Vascular Diseases
Cardiovascular Diseases
Brain Infarction
Brain Ischemia

ClinicalTrials.gov processed this record on May 16, 2013